AI is reviving an old solution against antimicrobial resistance Indeed, the World Health Organization (WHO) projects antimicrobial resistance (AMR) will cause 10 million annual deaths by 2050 and inflict significant economic harm Compounding this, the new antibiotic pipeline has nearly run dry, with almost no new antibiotics discovered in the last few decades
How market failures can help cause antibiotic resistance Antibiotics are highly successful in tackling infectious diseases but the pipeline for them has dried up and they have become less effective over time The main stumbling blocks are economic, not scientific, and the production and distribution of antibiotics is riddled with market and government failures If we fix the economics behind the discovery, manufacturing and distribution of
Are lower- and middle-income countries ready for the roll-out of anti . . . The growing range of anti-obesity medications could help stem the rise of non-communicable diseases in lower- and middle-income countries Health systems will need to secure equitable access to such drugs and ensure they are used in tandem with wider public-health programmes The lessons learned by wealthier countries implementing anti-obesity medications provide insights to potentially inform